These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1226841)

  • 1. [Pharmacodynamic effect of the combined administration of Hylase "Dessau" and Myocuran in ambulatory surgery].
    Bellmann H; Rauchfuss E; Böhland W; Scheuner G; Hutschenreiter J; Brand G; Sandner K
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1099-105. PubMed ID: 1226841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of Hylase in Bechterew's disease].
    Brand G; Bellmann H; Kothe W; Duck HJ; Rauchfuss E; Fleischmann H; Schönlebe W; Böhland W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1106-7. PubMed ID: 1226843
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiment findings on intravenous use of hylase "Dessau"].
    Kretschmar KH; Weidenbach H; Bellmann H; Petter O
    Exp Pathol (Jena); 1971; 5(3):212-6. PubMed ID: 4255705
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
    Wozniak KD; Braun W
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
    Nitzschner H
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topical therapy of musculo-articular diseases with a drug combination].
    Lanzara U; Esposito S
    Clin Ter; 1982 Apr; 101(2):143-9. PubMed ID: 7094546
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hylase Dessau in experimentally produced paratenonitis in the rabbit].
    Rauchfuss E; Bellmann H; Scheuner G; Hutschenreiter J; Kretschmar KH
    Z Exp Chir; 1973; 6(3):215-9. PubMed ID: 4772911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the antigenicity problems of Hylase "Dessau"].
    Müller HD
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1105-6. PubMed ID: 1226842
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences and experimental results with high-dose intravenous administration of hylase "Dessau"].
    Kretschmar KH; Bellmann H; Petter O; Senitz D; Zacharias J; Kretschmar K
    Dtsch Gesundheitsw; 1972 Aug; 27(34):1608-12. PubMed ID: 5080402
    [No Abstract]   [Full Text] [Related]  

  • 10. Muscle relaxants and antispasticity agents.
    Meleger AL
    Phys Med Rehabil Clin N Am; 2006 May; 17(2):401-13. PubMed ID: 16616274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of midocalm in combined treatment of neuropathic diabetic foot syndrome].
    Briskin BS; Sakunova TI; Iakobishvili IaI
    Khirurgiia (Mosk); 2000; (5):34-7. PubMed ID: 10842964
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyaluronic acid content and hyaluronidase activity in liver and spleen of rats with hydralazine-induced collagen-like syndrome.
    Drózdz M; Kula B; Wardas M; Weglarz L
    Biomed Biochim Acta; 1988; 47(3):247-50. PubMed ID: 3178790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous application of hylase "Dessau" on the blood-brain barrier].
    Senitz D; Fischer GJ
    Exp Pathol (Jena); 1972; 7(5):228-33. PubMed ID: 4660914
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spinal pain and its treatment with midocalm].
    Parfenov VA; Batysheva TT
    Ter Arkh; 2003; 75(5):82-3. PubMed ID: 12847906
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.
    Lambelin G; Roba J; Gillet C; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):610-8. PubMed ID: 4987564
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a combined muscle relaxant-analgesic as an effective therapy for painful skeletal muscle spasm.
    Scheiner JJ
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):168-77. PubMed ID: 4623596
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of the hyaluronic acid-hyaluronidase system in collagen diseases].
    BRAUNER R; SORU E; DEMAYO A
    Med Interna (Bucur); 1957 Mar; 9(3):323-37. PubMed ID: 13450858
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of intrathecal baclofen resistance to dose reduction.
    Cooper JA; Ridley B
    Neurology; 2006 Oct; 67(8):1495-6. PubMed ID: 17060585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue and systemic diffusion of idrocilamide after cutaneous administration].
    Bannwarth B; Le Huec JC; Vinçon G; Labat L; Demotes-Mainard F; Rivaille F; Le Rebeller A
    Rev Rhum Ed Fr; 1993 Dec; 60(12):932-6. PubMed ID: 8012322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.